Read More here.
177 Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I/II Trial | Journal of Nuclear Medicine
Level 20, Tower A, The Zenith
821 Pacific Highway
CHATSWOOD NSW 2067
PO Box 292, Gordon 2072. NSW
AUSTRALIATelephone: + 61 2 9144 2223
50 608 966 123
Which of the following group do you best fit?
Subscribe to our Email Alerts
Subscribe to our Emails and Newsletters